Written by Despite strong growth projections in the US Glioblastoma Market, high clinical attrition rates and significant economic burdens continue to present structural challenges to broader market entry.
Primary Challenges:
High Disease Recurrence: Genetic heterogeneity and cellular resistance mechanisms lead to tumor recurrence in the vast majority of patients, limiting long-term remission rates.
Blood-Brain Barrier (BBB) Obstacles: The physiological challenge of achieving efficient therapeutic drug delivery across the blood-brain barrier contributes to high failure rates in clinical trials.
Treatment Cost & Reimbursement Pressures: Advanced therapies, continuous device usage, and specialized care carry significant financial burdens, requiring extensive coverage coordination with private payers and Medicare.
Explore additional reports to understand evolving market landscapes:
Medical Imaging Displays Market Outlook
Radial Artery Compression Devices Market Analysis
Nanobiosensors in Healthcare Market Distribution
Transcatheter Embolization and Occlusion Devices Market Size